| Literature DB >> 35717735 |
Scott D Newsome1, Tory Johnson2.
Abstract
Stiff person syndrome spectrum disorders (SPSD) are a group of rare neuroimmunological disorders that often include painful spasms and rigidity. However, patients have highly heterogeneous signs and symptoms which may reflect different mechanistic disease processes. Understanding subsets of patients based on clinical phenotype may be important for prognosis and guiding treatment. The goal of this review is to provide updates on SPSD and its expanding clinical spectrum, prognostic markers, and treatment considerations. Further, we describe the current understanding in immunopathogenesis and highlight gaps in our knowledge appropriate for future research directions. Examples of revised diagnostic criteria for SPSD based on phenotype are also presented.Entities:
Keywords: Autoimmunity; GAD65; Glutamic acid decarboxylase; Stiff person spectrum disorders; Stiff person syndrome
Mesh:
Substances:
Year: 2022 PMID: 35717735 PMCID: PMC9274902 DOI: 10.1016/j.jneuroim.2022.577915
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.221